{"nctId":"NCT00965484","briefTitle":"Genotropin Study Assessing Use of Injection Pen","startDateStruct":{"date":"2009-10"},"conditions":["Growth Hormone Deficiency","Idiopathic Short Stature"],"count":136,"armGroups":[{"label":"Genotropin pen","type":"EXPERIMENTAL","interventionNames":["Device: New Genotropin Pen"]}],"interventions":[{"name":"New Genotropin Pen","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 8-18 years\n* Using genotropin pen for at least 3 months prior to study enrollment\n* Compliance with genotropin treatment\n\nExclusion Criteria:\n\n* Medical conditions that can affect participation in study\n* Insufficient command of English language to understand questionnaire\n* Using other growth hormone device and not Genotropin pen","healthyVolunteers":false,"sex":"ALL","minimumAge":"8 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Dyads (Participant and Caregiver or Parent) Reporting no Difference or Easier to Use for New Genotropin Mark VII Injection Pen Compared to Pre-study Experience With the Genotropin Pen®","description":"Ease of use measured using the Injection Pen Assessment Questionnaire (IPAQ) patient-reported outcome (PRO) tool (based on 13 unique characteristics of injection pens). Section I measures ease of use of Genotropin® (very easy, somewhat easy, neither easy nor difficult, somewhat difficult, or very difficult). Section II measures ease of use of new Genotropin Mark VII Pen in comparison to pre-study experience with Genotropin® Pen (Genotropin® pen easier to use, new injection pen easier to use, or no difference) and preference (prefer Genotropin® Pen, prefer new injection pen, or no preference).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73.68","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Dyads Reporting no Preference or Preference for New Genotropin Mark VII Injection Pen Compared to Pre-study Experience With the Genotropin Pen®","description":"Preference for use measured using IPAQ PRO tool (ease of use and preference based on 13 unique characteristics of injection pens). Section I measures ease of use of Genotropin® (very easy, somewhat easy, neither easy nor difficult, somewhat difficult, or very difficult). Section II measures ease of use of new Genotropin Mark VII Pen in comparison to pre-study experience with Genotropin® Pen (Genotropin® Pen easier to use, new injection pen easier to use, or no difference) and preference (prefer Genotropin® Pen, prefer new injection pen, or no preference).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65.15","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Dyads Reporting New Genotropin Mark VII Injection Pen Easier to Use Compared to Pre-study Experience With the Genotropin Pen®","description":"Ease of use measured using the IPAQ PRO tool (ease of use and preference based on 13 unique characteristics of injection pens). Section I measures ease of use of Genotropin® Pen (very easy, somewhat easy, neither easy nor difficult, somewhat difficult, or very difficult). Section II measures ease of use of new Genotropin Mark VII Pen in comparison to pre-study experience with Genotropin® Pen (Genotropin® Pen easier to use, new injection pen easier to use, or no difference) and preference (prefer Genotropin® Pen, prefer new injection pen, or no preference).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63.16","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Dyads Reporting New Genotropin Mark VII Injection Pen Preferable Compared to Pre-study Experience With the Genotropin Pen®","description":"Preference for use measured using IPAQ PRO tool (ease of use and preference based on 13 unique characteristics of injection pens). Section I measures ease of use of Genotropin® (very easy, somewhat easy, neither easy nor difficult, somewhat difficult, or very difficult). Section II measures ease of use of new Genotropin Mark VII Pen in comparison to pre-study experience with Genotropin® Pen (Genotropin® Pen easier to use, new injection pen easier to use, or no difference) and preference (prefer Genotropin® Pen, prefer new injection pen, or no preference).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.85","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":136},"commonTop":["Headache","Injection-site pain","Pyrexia","Upper respiratory tract infection","Injection-site hematoma"]}}}